Randox flying high at IFDAT with Virgin Atlantic contract
Leading drug and alcohol testing company Randox Testing Services has announced a prestigious contract win with one of the world’s most recognisable airlines – Virgin Atlantic.
The announcement was made as the company take centre-stage at the International Forum for Drug & Alcohol Testing, held in Titanic Belfast over Thursday & Friday.
The Co. Antrim headquartered company will supply random and with-cause testing services over the next three years, across both alcohol and drugs of abuse scenarios. Randox Testing Services collectors arrive on site, obtaining samples before these are transported under full chain of custody conditions to one of Randox’s secure laboratory facilities where they are tested for a wide range of substances.
Welcoming the deal Randox Testing Services Manager Gary McCutcheon said, “We are delighted to be partnering with Virgin Atlantic. They are one of the world’s outstanding airlines, and we know this deal demonstrates Randox Testing Services capacity to handle a global carrier.
“This is an exciting opportunity for us, as within aviation the Virgin brand represents customer service and quality. These are values that are at the centre of Randox Testing Services approach so we view it as an excellent fit.”
With the drug and alcohol screening industry’s main conference in Belfast this week Gary McCutcheon said the timing of the deal was perfect.
“The International Forum for Drug & Alcohol Testing is the premier event in the industry calendar so we are pleased everything was signed sealed and delivered in time. As host sponsor Randox Testing Services played a key role in bringing this international event to Belfast, so to be able to showcase such a landmark deal in front of peers and potential customers is a real bonus.”
Randox Testing Services provide drug & alcohol screening across a variety of safety critical sectors including aviation, construction and logistics. However the firm’s client base is broadening into more general corporate sectors as organisations recognise the changing landscape around corporate manslaughter as well as boosting productivity and morale.
The adaptability of Randox’s patented ground-breaking BioChip Array Technology provides the widest test menu available within the global market, including new psychoactive substances, colloquially known as ‘legal highs’.